Detailed View
ARQT - Arcutis Biotherapeutics, Inc.
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
3,178,749,696
Adj EBIT (TTM)
74,539,500
Enterprise Value
3,253,528,696
Last Price
25.29
Earnings Yield
2.29%
Return on Capital
23.70%
Capital
314,510,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 129,861,000 | 7,340,000 |
| 2026-03-31 | 10-Q | 2026 | 105,398,000 | -9,089,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 129,503,000 | 82,056,000 |
| 2025-09-30 | 10-Q | 2025 | 99,219,000 | -30,614,000 |
| 2025-06-30 | 10-Q | 2025 | 81,504,000 | -39,140,000 |
| 2025-03-31 | 10-Q | 2025 | 65,846,000 | -24,529,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 71,360,000 | 105,689,000 |
| 2024-09-30 | 10-Q | 2024 | 44,755,000 | -120,765,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.